08/05/2025
5:51 PM | BioMarin Pharmaceutical (Issuer)
CLARK IAN T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2025
5:55 PM | BioMarin Pharmaceutical (Issuer)
CLARK IAN T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2025
12:03 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/01/2025
8:18 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/17/2025
6:28 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/04/2025
3:32 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T/A | |
06/02/2025
5:25 AM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-T | |
05/20/2025
4:58 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2025
8:58 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2025
4:22 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
05/16/2025
8:44 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
Get the Latest News and Ratings for BMRN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioMarin Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. |
05/16/2025
4:16 PM | BioMarin Pharmaceutical (Filed by)
Inozyme Pharma, Inc. (Subject)
| Form SC TO-C | |
05/16/2025
6:54 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2025
6:59 AM | BioMarin Pharmaceutical (Subject)
| Form SC TO-C | |
05/13/2025
10:32 AM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
11:33 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025
9:05 AM | BioMarin Pharmaceutical (Subject)
Hubbard Cristin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
8:14 AM | BioMarin Pharmaceutical (Subject)
BlackRock, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
04/08/2025
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/08/2025
3:12 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2025
6:38 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
8:36 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2025
6:51 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:53 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:23 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:25 PM | BioMarin Pharmaceutical (Issuer)
Hubbard Cristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:17 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
5:22 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
3:11 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:15 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:17 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
6:19 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
3:18 PM | BioMarin Pharmaceutical (Issuer)
Walbert Timothy P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
7:21 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
12:54 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
9:26 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
1:14 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SCHEDULE 13G/A | |
12/03/2024
5:15 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
1:44 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
11/12/2024
1:27 PM | BioMarin Pharmaceutical (Subject)
Guyer Charles Greg (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024
2:01 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/01/2024
3:50 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/01/2024
3:51 PM | BioMarin Pharmaceutical (Issuer)
Friberg Gregory R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:29 PM | BioMarin Pharmaceutical (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
09/24/2024
7:31 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
4:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
11:52 AM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
4:02 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/22/2024
4:00 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
10:48 AM | BioMarin Pharmaceutical (Subject)
Burkhart Erin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
MarketBeat All Access